These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
380 related items for PubMed ID: 8598912
1. Telomerase activation by the E6 gene product of human papillomavirus type 16. Klingelhutz AJ, Foster SA, McDougall JK. Nature; 1996 Mar 07; 380(6569):79-82. PubMed ID: 8598912 [Abstract] [Full Text] [Related]
2. Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. Steenbergen RD, Walboomers JM, Meijer CJ, van der Raaij-Helmer EM, Parker JN, Chow LT, Broker TR, Snijders PJ. Oncogene; 1996 Sep 19; 13(6):1249-57. PubMed ID: 8808699 [Abstract] [Full Text] [Related]
3. Viral oncogenes accelerate conversion to immortality of cultured conditionally immortal human mammary epithelial cells. Garbe J, Wong M, Wigington D, Yaswen P, Stampfer MR. Oncogene; 1999 Apr 01; 18(13):2169-80. PubMed ID: 10327063 [Abstract] [Full Text] [Related]
4. Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro. Nakagawa S, Watanabe S, Yoshikawa H, Taketani Y, Yoshiike K, Kanda T. Virology; 1995 Oct 01; 212(2):535-42. PubMed ID: 7571423 [Abstract] [Full Text] [Related]
5. Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation. Liu Y, McKalip A, Herman B. J Cell Biochem; 2000 May 01; 78(2):334-49. PubMed ID: 10842327 [Abstract] [Full Text] [Related]
6. Impairment of the telomere/telomerase system and genomic instability are associated with keratinocyte immortalization induced by the skin human papillomavirus type 38. Gabet AS, Accardi R, Bellopede A, Popp S, Boukamp P, Sylla BS, Londoño-Vallejo JA, Tommasino M. FASEB J; 2008 Feb 01; 22(2):622-32. PubMed ID: 17898088 [Abstract] [Full Text] [Related]
7. Induction of the p53-target gene GADD45 in HPV-positive cancer cells. Butz K, Whitaker N, Denk C, Ullmann A, Geisen C, Hoppe-Seyler F. Oncogene; 1999 Apr 08; 18(14):2381-6. PubMed ID: 10327059 [Abstract] [Full Text] [Related]
8. Genomic instability and telomerase activity in human bronchial epithelial cells during immortalization by human papillomavirus-16 E6 and E7 genes. Coursen JD, Bennett WP, Gollahon L, Shay JW, Harris CC. Exp Cell Res; 1997 Aug 25; 235(1):245-53. PubMed ID: 9281374 [Abstract] [Full Text] [Related]
9. Inhibition of serum- and calcium-induced terminal differentiation of human keratinocytes by HPV 16 E6: study of the association with p53 degradation, inhibition of p53 transactivation, and binding to E6BP. Sherman L, Itzhaki H, Jackman A, Chen JJ, Koval D, Schlegel R. Virology; 2002 Jan 20; 292(2):309-20. PubMed ID: 11878933 [Abstract] [Full Text] [Related]
10. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. López-Ocejo O, Viloria-Petit A, Bequet-Romero M, Mukhopadhyay D, Rak J, Kerbel RS. Oncogene; 2000 Sep 21; 19(40):4611-20. PubMed ID: 11030150 [Abstract] [Full Text] [Related]
11. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes. Akerman GS, Tolleson WH, Brown KL, Zyzak LL, Mourateva E, Engin TS, Basaraba A, Coker AL, Creek KE, Pirisi L. Cancer Res; 2001 May 01; 61(9):3837-43. PubMed ID: 11325860 [Abstract] [Full Text] [Related]
12. Human papillomavirus type 16 E6 gene cooperates with EJ-ras to immortalize primary mouse cells. Storey A, Banks L. Oncogene; 1993 Apr 01; 8(4):919-24. PubMed ID: 8384359 [Abstract] [Full Text] [Related]
13. Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene. Demers GW, Halbert CL, Galloway DA. Virology; 1994 Jan 01; 198(1):169-74. PubMed ID: 8259651 [Abstract] [Full Text] [Related]
14. Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7. McMurray HR, McCance DJ. J Virol; 2004 Jun 01; 78(11):5698-706. PubMed ID: 15140967 [Abstract] [Full Text] [Related]
15. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes. Nees M, Geoghegan JM, Munson P, Prabhu V, Liu Y, Androphy E, Woodworth CD. Cancer Res; 2000 Aug 01; 60(15):4289-98. PubMed ID: 10945644 [Abstract] [Full Text] [Related]
16. Keratinocyte growth conditions modulate telomerase expression, senescence, and immortalization by human papillomavirus type 16 E6 and E7 oncogenes. Fu B, Quintero J, Baker CC. Cancer Res; 2003 Nov 15; 63(22):7815-24. PubMed ID: 14633708 [Abstract] [Full Text] [Related]
17. Abrogation of radiation-inducible telomerase upregulation in HPV16 E6 transfectants of human lymphoblasts. Neuhof D, Auberger F, Ruess A, Wenz F, Weber KJ. Strahlenther Onkol; 2004 Jan 15; 180(1):52-6. PubMed ID: 14704845 [Abstract] [Full Text] [Related]
18. HPV 16-E6-mediated degradation of intrinsic p53 is compensated by upregulation of p53 gene expression in normal cervical keratinocytes. Kawamata Y, Mitsuhashi A, Unno Y, Kado S, Shino Y, Uesugi K, Eguchi O, Ishii J, Seki K, Sekiya S, Shirasawa H. Int J Oncol; 2002 Sep 15; 21(3):561-7. PubMed ID: 12168100 [Abstract] [Full Text] [Related]
19. Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells. Pim D, Storey A, Thomas M, Massimi P, Banks L. Oncogene; 1994 Jul 15; 9(7):1869-76. PubMed ID: 8208532 [Abstract] [Full Text] [Related]
20. Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification. Hiller T, Poppelreuther S, Stubenrauch F, Iftner T. Cancer Epidemiol Biomarkers Prev; 2006 Jul 15; 15(7):1262-7. PubMed ID: 16835321 [Abstract] [Full Text] [Related] Page: [Next] [New Search]